Log In
Print
BCIQ
Print
Print this Print this
 

Botox, onabotulinumtoxinA (formerly botulinum toxin)

Also known as: BTX-A

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionVacuum-dried purified botulinum toxin type A
Molecular Target Not available
Mechanism of ActionInhibits neurotransmitter release
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$66,420.0M

$38,985.0M

$375.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today